Adhera Therapeutics, Inc.

ATRX

Adhera Therapeutics, Inc.

ATRX

Insider Sentiment (TTM):

Last Purchase:2017-06-09Last Sale:-Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2023-12-31Institutional Shares Owned:1Shares Outstanding:4,303,866Institutional Ownership Pct.:0.00%

Earnings Market Reaction:

Filing Date:2023-11-20Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Companies in Pharmaceutical Preparations

LLY JNJ ABBV MRK ABT PFE

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Assets
Assets Current
Prepaid Expense And Other Assets Current	-	-	-	-	-	-	-	-	-	-	-	-	0
Cash	0	0	0	0	0	1	0	0	0	0	0	0	-
Prepaid Expense Current	0	0	0	0	0	0	0	0	-	-	-	-	-
Assets Current	0	0	0	0	0	1	0	0	0	0	0	0	0
Assets	0	0	0	0	0	1	0	0	0	0	0	0	0
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	2	2	2	2	2	2	2	2	2	2	2	2	2
Due To Related Parties Current	-	-	-	0	0	0	0	0	0	0	0	0	0
Other Liabilities Current	-	0	0	-	-	-	-	-	-	-	-	-	-
Accrued Liabilities Current	6	5	5	4	4	4	3	3	3	3	2	2	2
Dividends Payable Current	1	1	1	0	0	0	6	5	5	5	4	4	4
Notes Payable	-	-	-	-	-	-	-	-	-	-	-	-	6
Notes Payable Current	-	-	-	-	-	-	-	-	-	-	6	6	-
Loans Payable Current	10	9	8	7	7	6	6	6	6	6	-	6	-
Convertible Notes Payable Current	1	1	1	1	1	1	1	1	1	1	-	1	-
Contract With Customer Liability Current	0	-	-	-	-	-	-	-	-	-	-	-	-
Derivative Liabilities Current	7	4	6	6	7	7	7	8	3	0	-	-	-
Liabilities Current	26	23	23	22	22	21	26	25	20	16	16	15	14
Liabilities	26	23	23	22	22	21	26	25	20	16	16	15	14
Stockholders Equity
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital	34	34	34	34	34	33	28	28	31	30	30	30	30
Treasury Stock Value	-0	-0	-0	-0	-0	-0	-	-	-	-	-	-	-
Retained Earnings Accumulated Deficit	-60	-56	-57	-56	-55	-54	-53	-53	-51	-47	-46	-45	-44
Stockholders Equity	-26	-23	-23	-22	-22	-20	-25	-25	-20	-16	-16	-15	-14
Liabilities And Stockholders Equity	0	0	0	0	0	1	0	0	0	0	0	0	0
Preferred Stock Par Or Stated Value Per Share	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01	0.01
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.006	0.006	0.006	0.006	0.006	0.006	0.006	0.006	0.006	0.006	0.006	0.01	0.006
Common Stock Shares Authorized	180	180	180	180	180	180	180	180	180	180	180	180	180
Common Stock Shares Issued	5	4	3	3	3	63	70	1	101	-	105	100	98
Shares Outstanding	5	4	3	3	3	4	2	1	2	2	2	2	98
Treasury Stock Shares	-	-	-	0	0	0	-	-	-	-	-	-	-
Treasury Stock Common Shares	0	0	0	-	-	-	-	-	-	-	-	-	-

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2023	-58.26%	-47.83%	-76.63%	-35.65%	-59.42%	-56.52%	62.50%	16.25%	-8.75%	-	-	-
2022	-4.12%	-4.12%	-1.47%	1.75%	-4.17%	-47.36%	-18.99%	-19.99%	-34.99%	2.96%	-81.14%	-91.42%
2021	114.29%	87.14%	96.43%	20.16%	60.21%	20.16%	-40.37%	-34.00%	-42.67%	-	-	-
2020	-	-	-	-	-	-	-	-	-	-45.00%	-40.00%	20.30%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Metrics	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30
Liquidity Ratios
Current Ratio	0.00	0.00	0.00	0.00	0.01	0.05	0.01	0.01	0.01	0.00	0.00	0.00	0.00
Quick Ratio	0.00	0.00	0.00	0.00	0.01	0.04	0.00	0.00	0.01	0.00	0.00	0.00	0.00
Working Capital	-26.32M	-22.79M	-23.09M	-22.19M	-21.81M	-20.00M	-25.50M	-25.11M	-20.24M	-16.34M	-15.51M	-14.77M	-14.03M
Leverage & Debt
Debt to Equity	-1.00	-1.00	-1.00	-1.00	-1.01	-1.05	-1.01	-1.01	-1.01	-1.00	-1.00	-1.00	-1.00
Debt Ratio	598.07	278.89	223.05	281.84	86.18	21.49	150.99	129.09	135.03	390.05	15,506.00	14,774.00	260.74
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.06
Per Share Metrics
Diluted EPS TTM	-0.87	-0.02	-	-	-1.99	-2.40	-	-	-	-	-	-	-
Free Cash Flow Per Share TTM	-0.17	-0.39	-0.47	-0.61	-0.52	-0.36	-0.32	-0.34	-0.24	-0.11	-0.13	-0.01	-0.03
Dividend Per Share TTM	0.03	0.03	0.09	0.27	0.54	0.61	0.73	0.77	0.39	0.40	0.62	0.02	0.02
Margin Metrics
Operating Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	-	-4,263.64%
Net Profit Margin TTM	-	-	-	-	-	-	-	-	-	-	-	-	-6,153.03%
Growth Metrics
Net Revenue Growth (1Y)	-	-	-	-	-	-	-	-	-100.00%	-100.00%	-100.00%	-100.00%	116.39%
Net Income Growth (1Y)	-40.56%	-75.51%	-69.25%	-74.85%	-6.31%	134.25%	115.99%	58.41%	-17.46%	-66.72%	-69.46%	-60.64%	-28.35%
EPS Growth (1Y)	-56.34%	-75.81%	-75.05%	-78.59%	-42.26%	33.21%	56.29%	7,966.21%	4,045.18%	1,574.02%	1,502.04%	-99.29%	-28.35%
Valuation Metrics
P/E TTM	-0.03	-0.09	-0.72	-0.90	-0.63	-0.50	-0.42	-0.35	-1.24	-1.18	-0.81	-15.64	-11.20
P/B TTM	-0.00	-0.01	-0.08	-0.09	-0.18	-0.21	-0.14	-0.12	-0.41	-0.25	-0.20	-5.62	-6.49
P/S TTM	-	-	-	-	-	-	-	-	-	-	-	-	689.23
Market Cap	129.12K	173.13K	1.85M	1.89M	3.98M	4.10M	3.56M	2.91M	8.29M	4.12M	3.17M	83.01M	90.98M
Enterprise Value	10.93M	10.71M	11.41M	10.45M	11.84M	10.60M	10.34M	9.49M	14.68M	10.58M	9.56M	95.65M	97.23M
Calculated Values
Free Cash Flow TTM	-714.19K	-1.35M	-1.51M	-1.42M	-1.65M	-1.24M	-835.00K	-665.00K	-459.00K	-216.00K	-240.00K	-588.00K	-3.04M
Net Debt	10.80M	10.53M	9.56M	8.55M	7.86M	6.50M	6.79M	6.59M	6.39M	6.45M	6.39M	12.64M	6.25M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
Valuation Ratios
P/CF TTM
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2017-06-09Purchase

Owner: Trieu, Vuong

Title: Chairman of the Board

Shares: 10,000

Price/Share: $0.39

Value: $3,900.00

Shares Owned: 11,127,141

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2017-06-08Purchase

Owner: Trieu, Vuong

Title: Chairman of the Board

Shares: 20,000

Price/Share: $0.39

Value: $7,800.00

Shares Owned: 11,117,141

Relationship: Director,Officer,TenPercentOwner

Ownership: Direct

2017-04-07Purchase

Owner: Ramelli, Joseph W.

Title: Chief Executive Officer

Shares: 22,500

Price/Share: $0.43

Value: $9,675.00

Shares Owned: 440,653

Relationship: Officer

Ownership: Direct

2017-04-05Purchase

Owner: Ramelli, Joseph W.

Title: Chief Executive Officer

Shares: 97,550

Price/Share: $0.31

Value: $30,240.50

Shares Owned: 405,153

Relationship: Officer

Ownership: Direct

2017-02-06Purchase

Owner: Trieu, Vuong

Title: Chairman of the Board

Shares: 862,068

Price/Share: $0.29

Value: $249,999.72

Shares Owned: 862,068

Relationship: Director,Officer,TenPercentOwner

Ownership: Indirect

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2017-06-09	Trieu, Vuong	Director,Officer,TenPercentOwner	Chairman of the Board	Direct	Purchase	10,000	0.39	$3,900.00	11,127,141	4
2017-06-08	Trieu, Vuong	Director,Officer,TenPercentOwner	Chairman of the Board	Direct	Purchase	20,000	0.39	$7,800.00	11,117,141	4
2017-04-07	Ramelli, Joseph W.	Officer	Chief Executive Officer	Direct	Purchase	22,500	0.43	$9,675.00	440,653	4
2017-04-05	Ramelli, Joseph W.	Officer	Chief Executive Officer	Direct	Purchase	97,550	0.31	$30,240.50	405,153	4
2017-02-06	Trieu, Vuong	Director,Officer,TenPercentOwner	Chairman of the Board	Indirect	Purchase	862,068	0.29	$249,999.72	862,068	4
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2023-12-31

0.00%

Inst. Shares: 1

Shares Outstanding: 4,303,866

2023-09-30

0.00%

Inst. Shares: 1

Shares Outstanding: 4,303,866

2023-06-30

0.00%

Inst. Shares: 1

Shares Outstanding: 3,462,539

2023-03-31

0.00%

Inst. Shares: 1

Shares Outstanding: 3,176,952

2022-12-31

0.00%

Inst. Shares: 1

Shares Outstanding: 2,307,534

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2023-12-31	1	4,303,866	0.00%
2023-09-30	1	4,303,866	0.00%
2023-06-30	1	3,462,539	0.00%
2023-03-31	1	3,176,952	0.00%
2022-12-31	1	2,307,534	0.00%
2022-09-30	1	3,160,877	0.00%
2022-06-30	1	3,420,249	0.00%
2022-03-31	1	2,576,877	0.00%
2021-12-31	1	1,964,100	0.00%
2021-09-30	1	1,947,963	0.00%
2021-06-30	1	1,944,963	0.00%
2021-03-31	1	1,864,589	0.00%
2020-12-31	1	1,864,589	0.00%
Data beyond 3 years is for subscribers only. Unlock 17+ years of financial data Start 7-day free trial

Adhera Therapeutics, Inc. (ATRX) — SEC Financial Statements & Analysis

Adhera Therapeutics, Inc. (ATRX) is a pharmaceutical preparations company, incorporated in DE. Adhera Therapeutics, Inc. trades on OTC as: ATRX. Based on its latest SEC filing (Form 10-Q, period ending 2023-09-30), Adhera Therapeutics, Inc. reported a -100.00% year-over-year revenue growth, a Debt-to-Equity ratio of -1.00x, a Price-to-Sales (P/S) ratio of 689.23x (TTM), a Price-to-Book (P/B) ratio of -0 (TTM), at a market cap of $129.12K. Figures below are sourced from SEC EDGAR, as-filed.

Net Revenue TTM Growth 1Y: -100.00%
Debt To Equity: -1.00x
P/S TTM: 689.23x
P/B TTM: -0
Market Cap: $129.12K

Data as of 2023-09-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Adhera Therapeutics, Inc. in?

Adhera Therapeutics, Inc. (ATRX) operates in the Pharmaceutical Preparations industry.

What is ATRX's market cap?

Adhera Therapeutics, Inc. (ATRX) has a market capitalization of $129.12K as of 2023-09-30.

What exchange does ATRX trade on?

Adhera Therapeutics, Inc. (ATRX) trades on the OTC.

Where is Adhera Therapeutics, Inc. incorporated?

Adhera Therapeutics, Inc. is incorporated in DE.

Adhera Therapeutics, Inc. (ATRX) — SEC Financial Statements & Analysis

Frequently Asked Questions

Research Faster.Invest Smarter.

Research Faster.
Invest Smarter.